- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
FDA clears incisions on femtosecond platform
The FDA has cleared the use of corneal and arcuate incisions on Ziemer Ophthalmic Systems’ femtosecond laser platform during cataract surgery.
Port, Switzerland-The FDA has cleared the use of corneal and arcuate incisions on Ziemer Ophthalmic Systems’ femtosecond laser platform during cataract surgery.
With the release of the upgrade module for the Femto LDV Z6-part of Ziemer’s Femto LDV Z Models-ophthalmologists in the United States are now able to offer a bladeless cataract surgery.
Further cataract modules for the Femto LDV Z models are currently in the final development phase and not cleared by the regulatory bodies.
For more articles in this issue of Ophthalmology Times eReport, click here.
To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.
